Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01200940 · ClinicalTrials.gov registry record · Phase 1
Metabolic Effects of Non-Nutritive Sweeteners
A Phase 1 study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 1
- Development phase
- 118
- Enrollment target
NCT01200940 is a Phase 1 study that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 118 participants.
The verdict
NCT01200940, a Phase 1 study, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 118 participants
- Enrollment target
Study Summary
Background: \- Artificial sweeteners, such as sucralose (brand name Splenda), are very commonly found in products such as diet soft drinks. Recently, researchers learned that these sweeteners may affect hormones in the body, especially when they are consumed in combination with real sugar. Changes in hormone levels may, in turn, result in changes in blood sugar, appetite, and weight. Researchers are interested in studying the effects of artificial sweeteners on the metabolism and hormonal levels of healthy volunteers. Objectives: * To study the effects that artificial sweeteners have on hormone levels, blood sugar, and appetite. * To evaluate whether artificial sweeteners change the rate at which food passes out of the stomach into the gut, or the rate at which the body absorbs sugar from the gut. * To evaluate the effects that different amounts of artificial sweeteners have on hormone levels. Eligibility: \- Healthy volunteers between 18 and 45 years of age. Design: * This study will require one screening visit and four testing visits, scheduled on different days. * At the screening visit, eligible participants will be screened with a physical examination, medical history, blood samples, and body measurements (including height, weight, body circumferences, and skin folds). Participants will also be asked about how much artificial sweetener they typically consume and will have taste tests, in which a small amount of flavored liquid is placed on the tongue and participants will name the flavor and rate its intensity. * Participants will have four glucose tolerance tests on four different days. In preparation for the test, participants will not eat or drink anything but water for 12 hours prior to the test. Blood will be drawn before the test, and participants will drink one of the following study liquids, selected at random: * Plain water * Water mixed with sucralose (the amount found in one 12 oz diet soft drink) * Water mixed with sucralose (the amount found
Interventions
- OTHER Control
- OTHER Aspartame
- OTHER Sucralose
- OTHER Acesulfame-Potassium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2010-11-04 |
| Est. Completion | 2017-03-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01200940
The ClinicalTrials.gov registry entry for NCT01200940 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Control is the first listed.
NCT01200940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01200940 about?
NCT01200940 is a clinical study titled "Metabolic Effects of Non-Nutritive Sweeteners". Background: \- Artificial sweeteners, such as sucralose (brand name Splenda), are very commonly found in products such as diet soft drinks. Recently, researchers learned that these sweeteners may affect hormones in the body, especially when they are consumed in combination with real sugar. Changes ...
What is the current status of trial NCT01200940?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 118 participants. The study started on 2010-11-04. Estimated completion is 2017-03-30.
What interventions are being tested in trial NCT01200940?
The interventions under investigation include: Control (OTHER), Aspartame (OTHER), Sucralose (OTHER), Acesulfame-Potassium (OTHER).
Who is sponsoring clinical trial NCT01200940?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.